Titan Biotech
687.50
-16.55(-2.35%)
Market Cap₹581.80 Cr
PE Ratio25.71
IndustryChemicals
Company Performance:
1D-2.35%
1M+51.03%
6M+53.58%
1Y+20.72%
5Y+337.90%
View Company Insightsright
Latest news about Titan Biotech
Titan Biotech Reports 8% Revenue Growth and Board Changes in Q1 FY2026 Aug 13, 2025
Titan Biotech Limited reported a 7.8% increase in standalone revenue to Rs. 46.50 crore and an 8.1% rise in net profit to Rs. 6.16 crore for Q1 FY2026. The company appointed Mr. Debendra Kumar Sabat as Additional Independent Director and re-appointed Mr. Naresh Kumar Singla and Mr. Suresh Chand Singla as Managing Directors for five-year terms. A final dividend of Rs. 2.00 per share was recommended for FY2025. The 33rd Annual General Meeting is scheduled for September 26, 2025, with e-voting facilities available for shareholders.